Additional file 5 of Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017
收藏数据链接：
官方服务：
资源简介：
Additional file 5. Basic characteristics of patients receiving OAT from 2014 to 2017 in Sweden and Norway. OAT = opioid agonist therapy, HCV = hepatitis C virus infection, DAA = direct-acting antiviral agent, CI = confidence interval. Sources: The Swedish Prescribed Drug Register (SPDR), The Norwegian Prescription Database (NorPD). *Exluding Ribavirin (J05AP01)
创建时间：
2020-07-01
